English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 13 May 2021, 22:04 HKT/SGT
Share:
    

Source: China Shineway Pharmaceutical Group Limited
President Xi Jinping reiterates the country's support for Traditional Chinese Medicine

BEIJING, May 13, 2021 - (ACN Newswire) - During his visit to Henan Province, Nanyang City yesterday, President Xi Jinping commented on the necessity to further develop Traditional Chinese Medicine, to interpret the principles of Traditional Chinese Medicine utilising modern science, and adopt a path on integrating Traditional Chinese medicine and Western drugs on clinical treatments.

Share prices of Traditional Chinese Medicine companies saw a notable surge today, among which includes Shineway Pharmaceuticals (02877.HK), which went up +7.64% today. Shineway's high quality products including its TCM Formula Granules will likely be benefited by China's strong support of Traditional Chinese Medicine, market sources said.

FINET News H.K.
http://www.shineway.com.hk/en/index.aspx


Topic: Press release summary
Source: China Shineway Pharmaceutical Group Limited

Sectors: Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

China Shineway Pharmaceutical Group Limited Related News
May 13, 2021 21:55 HKT/SGT
Shineway (2877.HK) Q1 revenue increased by 37.0%
Dec 1, 2020 04:40 HKT/SGT
China Shineway Pharmaceutical records 29.4% revenue growth in October
Nov 30, 2020 14:00 HKT/SGT
Shineway Pharmaceutical (2877.HK) recorded 29.4% revenue growth for October 2020
Nov 30, 2020 14:00 HKT/SGT
神威藥業 (02877.HK) 十月份單月營業額比去年同期錄得29.4%增長
Nov 30, 2020 14:00 HKT/SGT
神威药业 (02877.HK) 十月份单月营业额比去年同期录得29.4%增长
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575